The deletion or mutation of the CT element required for the binding of transcription factors SP1 and SP3 in the human lipoprotein LPL promoter led to a reduction of about 70–80% in promoter activity in a human monocytic leukemia cell line [40]. The gene discussed is SP3; the disease is monocytic leukemia.